头孢他啶/阿维巴坦联合疗法的作用：这个问题可能仍有待探讨。 - Suppr

Suppr

超能文献

A role for ceftazidime/avibactam combination therapy: the question may still be on the table.

作者信息

Volpicelli Lorenzo, Oliva Alessandra

机构信息

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

出版信息

Infection. 2024 Dec;52(6):2521-2522. doi: 10.1007/s15010-024-02331-9. Epub 2024 Jul 4.

DOI:10.1007/s15010-024-02331-9

PMID:38963608

Abstract

摘要

相似文献

A role for ceftazidime/avibactam combination therapy: the question may still be on the table.

Infection. 2024 Dec;52(6):2521-2522. doi: 10.1007/s15010-024-02331-9. Epub 2024 Jul 4.

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .

Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.

Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Isolate With KPC-33 Carbapenemase.

Front Microbiol. 2021 Sep 23;12:727946. doi: 10.3389/fmicb.2021.727946. eCollection 2021.

Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.

mSphere. 2022 Dec 21;7(6):e0048722. doi: 10.1128/msphere.00487-22. Epub 2022 Nov 14.

Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina.

Microbiol Spectr. 2022 Dec 21;10(6):e0373322. doi: 10.1128/spectrum.03733-22. Epub 2022 Nov 29.

Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy.

Eur J Clin Microbiol Infect Dis. 2023 Apr;42(4):431-439. doi: 10.1007/s10096-023-04577-x. Epub 2023 Feb 20.

In vitro antibacterial activity of ceftazidime/avibactam in combination against planktonic and biofilm carbapenemase-producing Klebsiella pneumoniae isolated from blood.

J Glob Antimicrob Resist. 2020 Dec;23:4-8. doi: 10.1016/j.jgar.2020.07.028. Epub 2020 Aug 15.

Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing .

Microb Drug Resist. 2019 Nov;25(9):1357-1364. doi: 10.1089/mdr.2018.0234. Epub 2019 Jul 11.

Evaluation of ceftazidime/avibactam alone and in combination with amikacin, colistin and tigecycline against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae by in vitro time-kill experiment.

PLoS One. 2021 Oct 14;16(10):e0258426. doi: 10.1371/journal.pone.0258426. eCollection 2021.

Diverse evolutionary trajectories of carbapenemase: unraveling the impact of amino acid substitutions on β-lactam susceptibility and the role of avibactam in driving resistance.

mSystems. 2025 Apr 22;10(4):e0018425. doi: 10.1128/msystems.00184-25. Epub 2025 Mar 11.

本文引用的文献

Effect of ceftazidime/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing : results from a multicentre retrospective study.

JAC Antimicrob Resist. 2022 Dec 7;4(6):dlac121. doi: 10.1093/jacamr/dlac121. eCollection 2022 Dec.

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).

Clin Microbiol Infect. 2022 Apr;28(4):521-547. doi: 10.1016/j.cmi.2021.11.025. Epub 2021 Dec 16.

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study.

Clin Infect Dis. 2021 Nov 2;73(9):1664-1676. doi: 10.1093/cid/ciab176.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验